Verastem, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31)
Verastem, Inc. (VSTM) reported Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) of $2.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses · last filed 2018-03-13
- Verastem, Inc. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.60K.
- Verastem, Inc. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for the quarter ending 2017-09-30 was -$10.60K.
- Verastem, Inc. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for fiscal 2017 was $2.00K, a 91.67% decline from fiscal 2016.
- Verastem, Inc. available-for-sale securities, continuous unrealized loss position, aggregate loss (deprecated 2018-01-31) for fiscal 2016 was $24.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$9.00K derived: sum of 2 quarters · filed 2018-03-13 | $2.00K 10-K · filed 2018-03-13 | |
| 2017-09-30 | -$10.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $400.00 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $11.00K 10-Q · filed 2017-08-08 | |||
| 2016-12-31 | $24.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |